-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Nurix Therapeutics, Maintains $32 Price Target

Benzinga·07/10/2026 11:58:16
Listen to the news
BTIG analyst Jeet Mukherjee reiterates Nurix Therapeutics (NASDAQ:NRIX) with a Buy and maintains $32 price target.